Melanoma
News
Adding GM-CSF to ipilimumab extends survival in metastatic melanoma
Major finding: One year after the start of therapy, 69% of patients given the combination therapy and 53% of those who got ipilimumab alone were...
Conference Coverage
Melanoma advances make chemo third-tier therapy
Article
A severe case of cutaneous squamous cell carcinoma keratoacanthoma type in a 55-year-old man
News
FDA approves two more drugs for advanced melanoma
News
Dual immunotherapy scores rapid response in metastatic melanoma
Major finding: Tumor reductions of at least 80% were seen at 12 weeks in 11 of 37 (30%) of patients.Data source: A phase-I, dose-ranging study of...
News
'Slow Mohs' advised for lentigo maligna
News
FDA advisory panel nixes approval of drug-device for liver metastases
News
Therapeutic combos make inroads in advanced melanoma
News
Melanoma increases in adolescents
Major finding: The incidence of melanoma has increased by an average of 2% per year for both boys and girls in the past 30 years.Data source: An...
Conference Coverage
One in four melanoma patients shun sunscreen
Major finding: About 27% of melanoma survivors reported never wearing sunscreen, and 2% reported using a tanning bed.Data source: A database...
News
Ipilimumab plus surgery boosted advanced melanoma survival
Major finding: The 5-year melanoma-specific survival rate was 51%, and the median overall survival duration was 60 months for patients with...